COVID-19 vaccines showed high efficacy against severe Omicron: US data

The Nation's Leading Newspaper

1/22/2022 7:15:00 AM

COVID-19 vaccines and boosters continued to have very high efficacy against severe outcomes during the Omicron wave of the virus, a large real-world study from the US Centers for Disease Control and Prevention (CDC) showed. READ:

The Nation's Leading Newspaper

AFP/ MANILA BULLETINThe paper evaluated data from more than 300,000 visits to emergency departments, urgent care clinics, and hospitalizations across 10 states from August 26, 2021 to January 5, 2022.During the period when the Delta variant was dominant, vaccine efficacy against Covid-19 hospitalization was 90 percent between 14-179 days after dose two of a vaccine, fell to 81 percent more than 180 days after the second dose, and rose to 94 percent 14 days or more after dose three.

After Omicron became dominant, the vaccine efficacy estimate against hospitalization between 14-179 days after dose two was 81 percent, 57 percent after more than 180 days from dose two, and 90 percent 14 or more days after dose three.A second CDC paper, based on data from 25 US state and local jurisdictions, found that vaccine efficacy against infection waned from 93 percent prior to Delta to around 80 percent when Delta became dominant, but protection against death remained stable and high at 94 percent.

Read more: Manila Bulletin News »

WATCH: Coast Guard sets up buoys with Philippine flag in West PH Sea

The 5 navigational buoys bearing the Philippine flag have been placed in Lawak Island, Likas Island, Parola Island, and Pag-asa Island in the West Philippine Sea, says the Philippine Coast Guard Read more >>

FDA Approval Never Happened For The Vaccines? Peter McCullough via YouTube Sige bakuna pa more at booster shots pa more lalo yung pfizer. Sabi nga nasa huli ang pagsisisi.

Ireland lifts most COVID curbs as Omicron infections fallThe stringent rules, beefed up last month as the variant prompted a surge of new infections — forcing nightclubs to close over the Christmas period — will be lifted from 0600 GMT Sarturday after new cases and other key indicators eased in recent weeks.

DOH records over 31K new COVID-19 casesBREAKING: DOH reports 31,173 new cases, bringing the national total to 3,324,478 as of January 20, 2022. Total recoveries have reached 2,995,961 (+26,298 new) while death toll is now at 53,153 (+110 new). READ:

Gov’t eyeing COVID-19 tests in pharmaciesMANILA, Philippines — The government will look into the possibility of conducting COVID-19 tests in pharmacies as they rolled out vaccination in select drugstores in Metro Manila on Thursday,

Villanueva: Covid-19 SRA should also cover pharmacists in vaccine centers | Butch FernandezSEN.  Joel Villanueva took up the cudgels for pharmacists doing Covid-19 vaccine jab work, stressing they too should be receive special risk allowance (SRA). “Pharmacists and other personnel in private drugstores who will serve as Covid-19 vaccination centers must receive the benefits granted to health workers under the 2022 national…

QC hires more contact tracers amid COVID-19 surge in NCRThe Quezon City government has hired 350 additional contact tracers amid the surge of COVID-19 cases, particularly in the National Capital Region.  

Acosta-led Dengvaxia 'publicity' contributed to COVID-19 vax hesitancy —DrilonSenate Minority Leader Franklin Drilon on Thursday said the Dengvaxia "publicity" led by Public Attorneys Office (PAO) chief Persida Acosta has contributed to the hesitancy of the public to take COVID-19 shots. BigManDrilon persidaacosta but kako pangalanan needs fertilizers for its farm. BigManDrilon persidaacosta Not only that. People cannot choose the vaccine brand they want. BigManDrilon persidaacosta People who are hesitant to this vaccine have some valid points. Bakit ba kailangan pilitin magpabakuna ang ayaw? Isa pa, hanggang kailan matatapos ang pagbabakuna na ito - nung una 2, ngayon 3 at sa Israel 4 dapat in a span of a year? Di ka ba magtataka nun?

WASHINGTON, United States — COVID-19 vaccines and boosters continued to have very high efficacy against severe outcomes during the Omicron wave of the virus, a large real-world study from the US Centers for Disease Control and Prevention (CDC) showed Friday. AFP/ MANILA BULLETIN The paper evaluated data from more than 300,000 visits to emergency departments, urgent care clinics, and hospitalizations across 10 states from August 26, 2021 to January 5, 2022. During the period when the Delta variant was dominant, vaccine efficacy against Covid-19 hospitalization was 90 percent between 14-179 days after dose two of a vaccine, fell to 81 percent more than 180 days after the second dose, and rose to 94 percent 14 days or more after dose three. After Omicron became dominant, the vaccine efficacy estimate against hospitalization between 14-179 days after dose two was 81 percent, 57 percent after more than 180 days from dose two, and 90 percent 14 or more days after dose three. A second CDC paper, based on data from 25 US state and local jurisdictions, found that vaccine efficacy against infection waned from 93 percent prior to Delta to around 80 percent when Delta became dominant, but protection against death remained stable and high at 94 percent. Vaccine efficacy against infection fell to 68 percent by the time Omicron emerged. The authors weren’t able to derive an estimate for vaccine efficacy against death during Omicron, because of a lag in reporting, but the broad scientific expectation is that it will remain very high. The paper also showed that while deaths among fully vaccinated people rose sharply during the Delta wave — totaling more than 20,000 people between July to November — unvaccinated people were still 16 times more likely to die during the same period. Protection was even greater for people who were boosted. Between October to November, unvaccinated people were around 50 times more likely to die from Covid than people who were vaccinated and boosted.